Dare Bioscience Inc — 貸借対照表 (NASDAQ:DARE) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 7.55 M55.81 M43.83 M21.28 M22.1 M32.47 M 負債合計 8.7 M17.05 M32.71 M26.33 M28.11 M29.63 M 純資産合計 -1.15 M38.75 M11.11 M-5.05 M-6.01 M2.84 M 負債および純資産合計 7.55 M55.81 M43.83 M21.28 M22.1 M32.47 M 有利子負債合計 —————— 純負債 ——————

ニュース

Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Lags Revenue Estimates

Daré Bioscience, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:DARE) 2026-03-26

Daré Bioscience extends NIH grant period for preterm birth drug

Dianthus Therapeutics, Inc. (DNTH) Reports Q4 Loss, Misses Revenue Estimates

uniQure (QURE) Reports Q4 Loss, Misses Revenue Estimates

Daré Bioscience、HPV治療の治験でFDAの承認を取得

Daré Bioscience gets FDA clearance for HPV treatment trial

Dare Bioscience、NasdaqでシリーズA優先株式とワラント募集を開始

Dare Bioscience launches preferred stock and warrant offering on Nasdaq

Dare Bioscience株、Bayerの撤退後もH.C. Wainwrightの買い推奨を維持

Dare Bioscience stock maintains Buy rating at H.C. Wainwright as Bayer exits

Daré Bioscience to regain rights to hormone-free contraceptive from Bayer